Great stuff... the 'long wait' is finally over.
"ResApp also advises that the startup of its US clinical study, SMARTCOUGH-C, is
progressing well with recruitment to begin this quarter. Details of the study are now
available on the US National Institutes of Health clinical trials database at
www.clinicaltrials.gov (NCT02973282). Institutional review board approvals are in
place, and Site Initiation Visits at the main sites and their multiple satellite sites will
take place shortly, during which clinical staff will be trained on the final approved
protocol. The Company expects rapid recruitment given the size of the participating
hospitals and the onset of winter in the US when there is a high prevalence of
respiratory disease."
We are now in business & now we all have an understanding of what needs to happen prior to the enrolment of patient #1 & the rumours about the trials not going ahead & the other crap bandied about on this website can cease...!
Also - the presentation on Wednesday to 40 Insto investors who are "invite only" and "who are new
to healthcare IT and e-health investment opportunities and looking to gain a more in-
depth understanding of the sector. " is extremely exciting.
After a long winter (no pun intended) it seems like we will resume the uptick & the first target will be to make new all-time highs.
Ann: ResApp to Present at Wilsons Healthcare IT Conference, page-2
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #